Morgan Stanley’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.82M Sell
460,000
-306,487
-40% -$2.55M ﹤0.01% 4512
2025
Q4
$6.37M Buy
766,487
+445,765
+139% +$4.8M ﹤0.01% 3997
2025
Q3
$4.68M Sell
320,722
-188,811
-37% -$2.26M ﹤0.01% 4210
2025
Q2
$5.73M Sell
509,533
-126,186
-20% -$978K ﹤0.01% 3949
2025
Q1
$3.62M Buy
635,719
+70,447
+12% +$718K ﹤0.01% 4196
2024
Q4
$5.55M Buy
565,272
+293,474
+108% +$2.52M ﹤0.01% 3906
2024
Q3
$2.22M Buy
271,798
+121,823
+81% +$1.22M ﹤0.01% 4574
2024
Q2
$2.01M Sell
149,975
-1,076,807
-88% -$32.1M ﹤0.01% 4565
2024
Q1
$56.9M Sell
1,226,782
-1,221,359
-50% -$63.2M ﹤0.01% 1633
2023
Q4
$165M Buy
2,448,141
+1,203,955
+97% +$73.7M 0.01% 1297
2023
Q3
$90.1M Buy
1,244,186
+42,651
+4% +$3.41M 0.01% 1126
2023
Q2
$89.4M Sell
1,201,535
-274,475
-19% -$16.2M 0.01% 1161
2023
Q1
$78.5M Buy
1,476,010
+198,904
+16% +$12.6M 0.01% 1208
2022
Q4
$86.3M Sell
1,277,106
-78,994
-6% -$7.27M 0.01% 1120
2022
Q3
$169M Buy
1,356,100
+375,774
+38% +$44.8M 0.02% 639
2022
Q2
$93.3M Buy
980,326
+355,839
+57% +$43.4M 0.01% 963
2022
Q1
$101M Buy
624,487
+261,113
+72% +$50.8M 0.01% 863
2021
Q4
$121M Buy
363,374
+81,513
+29% +$38.7M 0.01% 781
2021
Q3
$131M Buy
+281,861
New +$137M 0.02% 699

Other funds holding DNA